What supplements and dosages are recommended to prevent recurrent herpes labialis (cold sores)?

Supplement Recommendations for Cold Sore Prevention

For preventing recurrent cold sores (herpes labialis), L-lysine supplementation at doses of 1,000-3,000 mg daily may reduce outbreak frequency, though the evidence is mixed and antiviral medications remain the gold standard for suppression.

Primary Prevention Strategy: Antiviral Medications

The established approach for preventing recurrent herpes labialis is daily suppressive antiviral therapy, not supplements. While the guidelines provided focus primarily on genital herpes, the same antiviral principles apply to oral herpes labialis 1:

• Acyclovir 400 mg orally twice daily is the standard suppressive regimen 2
• Valacyclovir and famciclovir are also effective alternatives 3
• Suppressive therapy reduces recurrence frequency by ≥75% in patients with frequent outbreaks (≥6 per year) 2, 3

This approach has documented safety and efficacy for up to 5-6 years of continuous use 2, 3.

Supplement Evidence: L-Lysine

Dosing Considerations

The lysine literature shows dose-dependent effects:

Low doses (<1 g/day): Appear ineffective for prophylaxis 4

Moderate doses (1,000 mg/day):

• One controlled trial showed significantly fewer lesions compared to placebo over 12 months 5
• Serum lysine levels >165 nmol/ml correlated with decreased recurrence rates 5
• However, a 2017 systematic review concluded this dose range is "ineffective" without concurrent low-arginine diet 4

High doses (>3 g/day):

• May improve subjective patient experience of disease 4
• An uncontrolled survey (average dose 936 mg) reported 84% of users felt it prevented or decreased recurrence frequency 6, but this lacks the rigor of controlled trials

Clinical Bottom Line on Lysine

If pursuing lysine supplementation, use 1,000-3,000 mg daily, recognizing that evidence quality is limited and effects are modest at best 4, 7. The most rigorous evidence suggests maintaining serum levels above 165 nmol/ml may be necessary for benefit 5.

Important Caveats

• Cardiovascular and gallbladder disease patients should be cautioned about theoretical risks of lysine supplementation 4
• Lysine should not replace antiviral therapy in patients with frequent or severe recurrences
• Longer-duration controlled studies are needed to definitively establish efficacy 4

Other Supplements Mentioned

The literature briefly mentions vitamin C, zinc, vitamin E, adenosine monophosphate, and lemon balm (Melissa officinalis) as potential alternatives 7, but no specific dosing or quality evidence is provided in these sources.

Practical Algorithm

For patients with frequent recurrences (≥6/year):

1. First-line: Daily suppressive antiviral therapy (acyclovir 400 mg BID) 2, 3
2. Reassess after 1 year to determine if continued suppression is needed 2, 3

For patients preferring non-pharmaceutical approaches or with infrequent recurrences:

1. Consider L-lysine 1,000-3,000 mg daily 5, 4
2. Screen for cardiovascular/gallbladder contraindications 4
3. Set realistic expectations: effects are modest and inconsistent
4. Consider adding low-arginine diet for potential synergy 4

For all patients:

• Sunscreen or zinc oxide application to lips may help prevent UV-triggered recurrences 1
• Early episodic treatment with antivirals at first prodrome remains an option 3